Drug Shortage Report for MEPRON
| Report ID | 41792 |
| Drug Identification Number | 02217422 |
| Brand name | MEPRON |
| Common or Proper name | Atovaquone Oral Suspension |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATOVAQUONE |
| Strength(s) | 750MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 210 mL |
| ATC code | P01AX |
| ATC description | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS. |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-03-05 |
| Estimated end date | 2018-05-07 |
| Actual end date | 2018-03-28 |
| Shortage status | Resolved |
| Updated date | 2018-03-29 |
| Company comments | For emergency supply, contact GSK Customer Service 1-800-387-7374. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-03-05 | English | Compare |
| v2 | 2018-03-05 | French | Compare |
| v3 | 2018-03-06 | English | Compare |
| v4 | 2018-03-29 | English | Compare |
| v5 | 2018-03-29 | French | Compare |
Showing 1 to 5 of 5